Table 2. Demographic data of the study population.
Demographic data | Total sample (n= 88) | No dysfunction (n = 62) | Asymptomatic dysfunction | Test of sig. | p-value | |
Mild (n = 18) | Moderate (n = 8) | |||||
No. (%) | No. (%) | No. (%) | ||||
Gender | ||||||
Male | 7 (8%) | 4 (6.5%) | 1(5.6%) | 2 (25%) | χ2=3.167 | MCp=0.185 |
Female | 81 (92%) | 58 (93.5%) | 17 (94.4%) | 6 (75%) | ||
Age (years) | 43.33 ± 12.36 | 42.65 ± 11.41 | 47.06 ± 14.85 | 40.25 ± 13.37 | F=1.165 | 0.317 |
Type of malignancy | ||||||
Other types | 15 (17%) | 10 (16.1%) | 3 (16.7%) | 2 (25%) | MCp=0.724 | |
BC | 73 (83%) | 52 (83.9%) | 15 (83.3%) | 6 (75%) | ||
Baseline HR | 81.95 ± 15.40 | 83.10 ± 14.25 | 76.0 ± 17.43 | 86.50 ± 17.68 | F=1.904 | 0.155 |
Baseline risk factors | ||||||
DM | 3 (3.4%) | 1 (1.6%) | 1 (5.6%) | 1 (12.5%) | χ2=3.549 | MCp=0.123 |
HTN | 14 (15.9%) | 9 (14.5%) | 3 (16.7%) | 2 (25%) | χ2=0.988 | MCp=0.718 |
Smoking | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | – | – |
Family history | 1 (1.1%) | 0 (0%) | 0 (0%) | 1 (12.5%) | χ2=5.478 | MCp=0.095 |
BSA | 1.89 ± 0.24 | 1.89 ± 0.25 | 1.88 ± 0.21 | 1.90 ± 0.24 | F=0.010 | 0.990 |